Cargando…
Improvement of Sodium Status to Optimize the Efficacy of Renin-Angiotensin System Blockade
Blockade of the renin-angiotensin-aldosterone system (RAAS) offers superior renoprotection in the treatment of patients with hypertension, but the efficacy of RAAS inhibition strongly depends on sodium status, presumably in relation to extracellular volume status. Because assessing volume status by...
Autores principales: | Laverman, Gozewijn D., Navis, Gerjan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212696/ https://www.ncbi.nlm.nih.gov/pubmed/21964882 http://dx.doi.org/10.1007/s11906-011-0234-7 |
Ejemplares similares
-
Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial
por: Slagman, Maartje C J, et al.
Publicado: (2011) -
Effects of Dapagliflozin on Volume Status When Added to Renin–Angiotensin System Inhibitors
por: Eickhoff, Mie K., et al.
Publicado: (2019) -
The role of renin-angiotensin system in patients with left ventricular assist devices
por: Briasoulis, Alexandros, et al.
Publicado: (2020) -
Is angiotensin-(3–4) (Val-Tyr), the shortest angiotensin II-derived peptide, opening new vistas on the renin–angiotensin system?
por: Dias, Juliana, et al.
Publicado: (2017) -
Renin-angiotensin system blockers and COVID-19
por: Vidal-Petiot, Emmanuelle, et al.
Publicado: (2021)